Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

March 2019

Reminder: Anser IFX, UST, and VDZ Tests Not Covered


As a reminder, Harvard Pilgrim does not cover the following Anser tests, which are conducted to measure serum levels of infliximab and antibodies to infliximab:

  • Anser IFX
  • Anser UST
  • Anser VDZ

Harvard Pilgrim regularly reviews published medical and scientific literature to determine clinical appropriateness. Based on this ongoing review, these tests are considered experimental/investigational because literature does not support their safety and/or efficacy. These tests have been added to Harvard Pilgrim’s New Technology Assessment and Non-Covered Services Medical Policy.

Email this article to a colleague   


Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Harvard Pilgrim Network Meeting: Sign Up for the Mass. Event

CLINICIAN CORNER

Update: Emergency Care and Controlled Substances

Updates to Medical Policies

Udenyca Now Covered with Prior Authorization

Reminder: Anser IFX, UST, and VDZ Tests Not Covered

OFFICE ASSISTANT

Guidance Regarding Procedures Designated as a “Separate Procedure”

Keep Panel Status and Demographic Information Up to Date

PUBLICATION INFORMATION

Robert Farias,
Senior Vice President, Corporate Network Strategy

Annmarie Dadoly,
Editor

Joseph O'Riordan,
Writer

Kristin Edmonston,
Production Coordinator